2017 American Transplant Congress » Concurrent Session: Liver: Immunosuppression and Rejection

Date: Tuesday, May 2, 2017

Time: 4:30pm-6:00pm

Location: E451b

Session Type: Concurrent Session

Meeting: 2017 American Transplant Congress

4:30pm-4:42pm: Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.

C. Jadlowiec, P. Morgan, A. Nehra, M. Hathcock, W. Kremers, R. Wiesner, T. Taner.

4:42pm-4:54pm: Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial.

F. Saliba,¹ C. Duvoux,² S. Dharancy,³ J. Dumortier,⁴ Y. Calmus,⁵ F. Di Giambattista,⁶ F. Conti.⁵

4:54pm-5:06pm: A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-Incompatible Living Donor Liver Transplantation.

E. Lee, S. Kim, S. Lee, S.-J. Park.

5:06pm-5:18pm: No Gains in Long-Term Survival Following Liver Transplantation Over the Past Three Decades.

A. Rana,¹ M. Kueht,¹ J. Moffett,¹ N. Galvan,¹ R. Cotton,¹ J. Vierling,^1,2 A. Mindikoglu,^1,2 C. O'Mahony,¹ J. Goss.¹

5:18pm-5:30pm: FOXP3 rs3761548 A/C+A/A Genotype Is a Risk Factor for Steroid Resistant Rejection After Liver Transplantation.

Y. Tanaka, V. Sapana, H. Ohdan.

5:30pm-5:42pm: The Combined Effects of Induction Regimens and Antiviral Prophylaxis on the Risk of CMV Infection in Different Serostatus Subgroups After Liver Transplantation.

C. Low,² S. Hosseini-Moghaddam,^1,2 C. Rotstein,² E. Renner,² A. Humar,² D. Kumar,² S. Husain.²

5:42pm-5:54pm: Impact of a B-Cell Targeting Agent on Antibody Mediated Rejection and Graft' Survival in Liver Transplantation with Preformed DSAs.

A. Del Bello,¹ V. Dubois,² J. Dumortier,³ N. Congy-Jolivet,⁴ N. Kamar.¹

« View all sessions from the 2017 American Transplant Congress